Mircea Gabriel Stoleriu
Overview
Explore the profile of Mircea Gabriel Stoleriu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
111
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Fischer A, Han W, Hu S, Muck-Hausl M, Wannemacher J, Kadri S, et al.
Nat Commun
. 2025 Feb;
16(1):1911.
PMID: 39994215
No abstract available.
2.
Melo-Narvaez M, Golitz F, Jain E, Gote-Schniering J, Stoleriu M, Bertrams W, et al.
Respir Res
. 2025 Feb;
26(1):57.
PMID: 39962456
Background: Human precision-cut lung slices (hPCLS) are a unique platform for functional, mechanistic, and drug discovery studies in the field of respiratory research. However, tissue availability, generation, and cultivation time...
3.
Zimmermann J, Walter J, Pfeiffer V, Kovacs J, Yavuz G, Schon J, et al.
J Cardiothorac Surg
. 2025 Jan;
20(1):96.
PMID: 39865313
Background: Lymph node upstaging represents a quality criterion for standardized lymphadenectomy in lung cancer surgery. The aim of the study was to compare whether the quality of standardized lymphadenectomy in...
4.
Fischer A, Han W, Hu S, Hausl M, Muck-Hausl M, Wannemacher J, et al.
Nat Commun
. 2025 Jan;
16(1):173.
PMID: 39747171
Lung fibrosis development utilizes alveolar macrophages, with mechanisms that are incompletely understood. Here, we fate map connective tissue during mouse lung fibrosis and observe disassembly and transfer of connective tissue...
5.
Damirov F, Stoleriu M, Manapov F, Boedeker E, Dreher S, Gerz S, et al.
Cancers (Basel)
. 2024 Aug;
16(16).
PMID: 39199656
Our study aimed to identify predictors for the effectiveness of tumor regression in lung cancer patients undergoing neoadjuvant treatment and cancer resections. Patients admitted between 2016 and 2022 were included...
6.
Stoleriu M, Pienn M, Joerres R, Alter P, Fero T, Urschler M, et al.
Int J Chron Obstruct Pulmon Dis
. 2024 Jul;
19:1515-1529.
PMID: 38974817
Purpose: The aim of this study was to evaluate the association between computed tomography (CT) quantitative pulmonary vessel morphology and lung function, disease severity, and mortality risk in patients with...
7.
Stoleriu M, Ansari M, Strunz M, Schamberger A, Heydarian M, Ding Y, et al.
Thorax
. 2024 Jan;
79(6):524-537.
PMID: 38286613
Introduction: Environmental pollutants injure the mucociliary elevator, thereby provoking disease progression in chronic obstructive pulmonary disease (COPD). Epithelial resilience mechanisms to environmental nanoparticles in health and disease are poorly characterised....
8.
Rubio K, Muller J, Mehta A, Watermann I, Olchers T, Koch I, et al.
Discov Oncol
. 2023 Oct;
14(1):181.
PMID: 37787775
Background: Lung cancer (LC) causes more deaths worldwide than any other cancer type. Despite advances in therapeutic strategies, the fatality rate of LC cases remains high (95%) since the majority...
9.
Chen J, Wang X, Schmalen A, Haines S, Wolff M, Ma H, et al.
Eur Respir J
. 2023 Jun;
62(2).
PMID: 37385655
Background: Virus infections drive COPD exacerbations and progression. Antiviral immunity centres on the activation of virus-specific CD8 T-cells by viral epitopes presented on major histocompatibility complex (MHC) class I molecules...
10.
Damirov F, Stoleriu M, Manapov F, Busing K, Michels J, Preissler G, et al.
Diagnostics (Basel)
. 2023 Jun;
13(11).
PMID: 37296745
This study aimed to evaluate the diagnostic accuracy and false positivity rate of lymph node (LN) staging assessed by integrated 18F-fluorodeoxyglucose positron emission computed tomography (18F-FDG-PET/CT) in patients with operable...